Dr. Masaki Tanito is a distinguished Professor and Chairman in the Department of Ophthalmology at Shimane University Faculty of Medicine, Japan. He is a leading expert in ophthalmology, with over two decades of experience in both clinical practice and research. His work focuses primarily on glaucoma surgery, vitreoretinal surgery, corneal transplantation, and cataract surgery. Dr. Tanito’s research contributions have advanced the understanding of glaucoma, particularly in diagnostic technology and oxidative stress measurement. He has published over 280 research papers, making significant strides in medical science and ophthalmology. His global academic collaborations, leadership roles in several prestigious societies, and numerous accolades highlight his standing in the field. Dr. Tanito has also mentored young researchers and continues to contribute to the development of new techniques and treatments in ophthalmology.
Professional Profile
Education:
Dr. Tanito’s educational background is rooted in esteemed institutions. He earned his MD from Shimane Medical University, Faculty of Medicine, in 1996, which marked the beginning of his academic career in ophthalmology. Subsequently, he pursued advanced studies, culminating in a PhD in Medicine (Ophthalmology) from Shimane Medical University in 2003. His academic journey is marked by a commitment to both learning and teaching, as he consistently sought opportunities for research and development. This robust foundation in medicine and ophthalmology has paved the way for his extensive contributions to the field. Throughout his career, he has maintained a strong commitment to education, frequently mentoring medical students and researchers.
Professional Experience:
Dr. Tanito’s professional journey is highlighted by his long-standing commitment to ophthalmology. He is currently the Professor and Chairman of the Department of Ophthalmology at Shimane University Faculty of Medicine, a position he has held since 2018. Prior to this, he served as Director General of the Division of Ophthalmology at Matsue Red Cross Hospital from 2014 to 2018. His early career included roles as Associate Professor and Assistant Professor at Shimane Medical University, where he worked on advancing clinical practices and research. His international experience includes positions as a visiting scientist at the University of Oklahoma Health Sciences Center and Kyoto University. This diverse experience has allowed him to contribute both locally and globally to the advancement of ophthalmology. As an educator, he plays a crucial role in shaping the future of ophthalmology in Japan.
Research Interest:
Dr. Tanito’s research interests are focused on various aspects of ophthalmology, particularly in the area of glaucoma. His work involves developing new techniques for glaucoma surgery, enhancing diagnostic technologies for better disease management, and measuring oxidative stress in glaucoma subjects. This has led to significant advances in understanding the underlying mechanisms of glaucoma and improving patient care. His research also extends to vitreoretinal surgery, corneal transplantation, and cataract surgery. Through his work, Dr. Tanito has explored innovative solutions to enhance the outcomes of ophthalmic procedures. Additionally, his work on oxidative stress measurement holds promise for advancing personalized treatment approaches for glaucoma patients. His research contributions have a profound impact on clinical practices and surgical innovations, positioning him as a leader in the ophthalmology research community.
Research Skills:
Dr. Tanito possesses a wide range of research skills that have contributed to his success as an ophthalmology researcher. His ability to conduct and analyze complex clinical studies, particularly in glaucoma, is central to his research. He has a strong foundation in diagnostic technology development, enabling him to design and implement innovative tools to improve early detection and management of ocular diseases. His expertise in oxidative stress and its role in glaucoma highlights his interdisciplinary research capabilities, bridging biochemistry and ophthalmology. Moreover, Dr. Tanito is skilled in clinical trial design and execution, ensuring that his research has real-world applications. His extensive experience in laboratory and clinical settings has led to numerous collaborations and groundbreaking findings. As a mentor and leader, he also fosters the development of research teams, sharing his skills and knowledge to further enhance the field of ophthalmology.
Awards and Honors:
Dr. Tanito has received numerous awards and honors throughout his career, recognizing his contributions to ophthalmology. Notably, he was honored with the Young Investigator Award by the Japanese Society for Photomedicine and Photobiology in 2007. His commitment to advancing glaucoma research was acknowledged through the Imai Memorial Glaucoma Research Fellowship and the Suda Memorial Glaucoma Research Fellowship. In addition, he was awarded the Academic Award from the Society of Free Radical Research Japan in 2022 and the Society Award from the Japanese Society for Photochemistry and Photobiology in 2024. These prestigious awards reflect his ongoing influence in the field and his exceptional contributions to medical science. Furthermore, his career has been supported by competitive research fellowships, such as the Japan Society for the Promotion of Science (JSPS) Research Fellowship. These accolades highlight his standing as a leading researcher in ophthalmology.
Conclusion:
Dr. Masaki Tanito is a leading figure in the field of ophthalmology, with a distinguished career marked by groundbreaking research, clinical excellence, and leadership. His extensive body of work, particularly in the areas of glaucoma surgery and oxidative stress measurement, has advanced the understanding and treatment of ocular diseases. His impressive list of awards, research publications, and academic positions speaks to his expertise and influence in the field. Dr. Tanito’s mentorship and contributions to the development of new ophthalmic technologies further solidify his role as a pioneer in the discipline. While his research continues to have a significant impact on clinical practices, opportunities for further interdisciplinary collaboration and public engagement could enhance his future contributions. Overall, Dr. Tanito’s career reflects a commitment to both advancing the science of ophthalmology and improving patient care globally. He remains a prominent leader and innovator in the field of ophthalmic research and clinical practice.
Publication Top Notes
- Title: Transient anterior subcapsular vacuolar lens opacities after Tanito microhook trabeculotomy: report of six cases
Authors: Shimizu, H., Tanito, M.
Journal: BMC Ophthalmology, 2024, 24(1), 227
- Title: Potentially compromised systemic and local lactate metabolic balance in glaucoma, which could increase retinal glucose and glutamate concentrations
Authors: Arai-Okuda, M., Murai, Y., Maeda, H., Yamada-Nakanishi, Y., Nakamura, M.
Journal: Scientific Reports, 2024, 14(1), 3683
- Title: A Novel Approach To Predict Glaucomatous Impairment in the Central 10° Visual Field, Excluding the Effect of Cataract
Authors: Tomita, R., Asaoka, R., Hirasawa, K., Nishiguchi, K.M., Tanito, M.
Journal: Translational Vision Science and Technology, 2024, 13(10), 35
- Title: Association Analysis between Cognitive Function Score and Inner Macular Thickness/Visual Field Sensitivity in Glaucoma Patients
Authors: Shimomine, S., Kubota, S., Kadoh, Y., Tanito, M.
Journal: Journal of Clinical Medicine, 2024, 13(17), 5086
- Title: Exploring Cognitive Impairments Associated with Primary Open-Angle Glaucoma and Exfoliation Glaucoma
Authors: Kadoh, Y., Kubota, S., Shimomine, S., Tanito, M.
Journal: Biomedicines, 2024, 12(8), 1706
Citations: 1
- Title: Intraocular Pressure Changes in Non-Surgical Eyes of Patients Admitted for Glaucoma Surgery
Authors: Kubota, S., Shimomine, S., Kadoh, Y., Tanito, M.
Journal: Journal of Clinical Medicine, 2024, 13(15), 4511
- Title: Effect of ripasudil after trabeculectomy with mitomycin C: A multicentre, randomised, prospective clinical study
Authors: Muhlisah, A., Hirooka, K., Nurtania, A., Nakakura, S., Kiuchi, Y.
Journal: BMJ Open Ophthalmology, 2024, 9(1), e001449
- Title: Association between Skin Carotenoid Levels and Cognitive Impairment Screened by Mini-Cog in Patients with Glaucoma
Authors: Takayanagi, Y., Kadoh, Y., Sasaki, J., Obana, A., Tanito, M.
Journal: Current Issues in Molecular Biology, 2024, 46(7), pp. 6940–6950
- Title: Assessing the Impact of PRESERFLO MicroShunt on Intraocular Pressure in Porcine Eyes Ex Vivo Using Infusion Pump System
Authors: Masdipa, A., Kaidzu, S., Tanito, M.
Journal: Bioengineering, 2024, 11(7), 669
- Title: Construction of a screening system for lipid-derived radical inhibitors and validation of hit compounds to target retinal and cerebrovascular diseases
Authors: Mori, R., Abe, M., Saimoto, Y., Morimoto, K., Yamada, K.-I.
Journal: Redox Biology, 2024, 73, 103186
Citations: 1